Description: The American Journal of Endocannabinoid Medicine provides the latest insights, facts, news, and information related to cannabis in medicine.
AJEM is the first and only American medical authority committed to the scientific study of the endocannabinoid system (ECS) and to the practice of evidence-based cannabinoid medicine.
Introduction: Widespread access to both prescribed opioid medications and illicit narcotics (including heroin and clandestine fentanyl) have contributed to the opioid epidemic in the United States. From 1999 to 2018, nearly 450,000 Americans have died of an opioid overdose, and since 2016, the Centers for Disease Control and Prevention report an average of 130 deaths […]
With false claims circulating about the effectiveness of cannabis to treat COVID-19 and studies rapidly pouring out of labs and hospitals, it is challenging to make sense of it all. AJEM spoke with leading cannabis researchers and physicians to reflect on what we’ve learned after a year of COVID-19. In short, it’s complicated. Medical cannabinoid […]